You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Science takes over the city.
HHMI announces 56 new appointees.
A blogger wonders what students do after leaving academia.
Beth Israel Deaconess and the Cleveland Clinic try Google Health out.
A check in the column for personalized medicine.
A blogger wonders where all the scientific geniuses have gone.
A new initiative aims to bring the humanities and science together.
Takeda looks at US market.
Research links genetics to political stance.
Sheer luck has little to do with scientific success, says a blogger.
A blogger notes that the proposal submission deadline for January's PSB meeting is approaching.
A blogger suggests some ways to clean up your file- and directory-naming protocol.
After our sigh of relief as GINA became law, a Wired blogger says we've still got things to worry about.
Google Trends indicates that synthetic biology captures just a sliver of the interest that's seen for systems biology.
This Science roundup includes Australia's science budget, reviews of systems biology books, endogenous siRNAs, and more.
Find yourself without the requisite number of scientist buddies? A couple of social networking sites want to help.
Scientists compare the microbiome across 60 mammalian species.
A blogger describes a new paper from Benjamin Cravatt's lab.
A blogger makes the case for open access to chemistry data.
Virginia Commonwealth University has a contract with Philip Morris that prevents professors from publishing without the company's consent, reports the New York Times.
A blogger considers her first year in academia.
A pharma strives to minimize bureaucracy by streamlining.
A blogger discusses the discovery of a novel protein-coding gene in yeast.
US News & World Report says hurray for GINA, but genetic testing is still hampered by lack of coverage among third-party payers.
This week in Nature there's open-access publishing, genetic testing, stem cells, and more.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.